Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRA | AMGN | GILD | VRTX | BIIB |
| Company | Atara Biotherap | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6884 | 272.14 | 67.09 | 404.00 | 193.34 |
| High | 0.7243 | 274.48 | 67.68 | 406.86 | 195.86 |
| Low | 0.6664 | 271.05 | 67.00 | 403.47 | 192.75 |
| Last | 0.7186 | 273.54 | 67.03 | 404.91 | 193.18 |
| Change | +0.0212 | +1.63 | +0.08 | +4.99 | -0.93 |
| % Change | +3.04% | +0.60% | +0.12% | +1.25% | -0.48% |
| Volume | 833,900 | 2,493,300 | 5,240,200 | 1,070,300 | 1,461,600 |
| 20-Day Average Volume | 1,126,610 | 2,216,505 | 6,335,325 | 977,305 | 1,180,210 |
| Previous Close | 0.6974 | 271.91 | 66.95 | 399.92 | 194.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7134 | 271.99 | 69.34 | 404.17 | 202.66 |
| 20-Day Raw Stochastic | 46.55% | 46.12% | 14.18% | 45.66% | 13.30% |
| 20-Day Relative Strength | 50.53% | 48.69% | 32.82% | 47.90% | 31.60% |
| Weighted Alpha | -62.66 | +11.45 | -20.86 | +17.74 | -38.57 |
| Today's Opinion | 40% Sell | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Previous Opinion | 56% Sell | 40% Sell | 100% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 72% Sell | 8% Buy | 88% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.43% since 04/16/24 | +2.97% since 04/16/24 | -0.42% since 04/16/24 | +2.72% since 04/16/24 | -1.01% since 04/16/24 |
| Low | 0.6401 on 04/19/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.7401 on 04/18/24 | 274.48 on 04/23/24 | 67.68 on 04/23/24 | 406.86 on 04/23/24 | 196.77 on 04/22/24 |
| 1-Month | |||||
| %Chg | +3.04% since 03/22/24 | -0.95% since 03/22/24 | -7.68% since 03/22/24 | -2.59% since 03/22/24 | -11.43% since 03/22/24 |
| Low | 0.6194 on 03/26/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.8325 on 04/04/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 218.26 on 03/25/24 |
| 3-Month | |||||
| %Chg | +19.57% since 01/23/24 | -11.74% since 01/23/24 | -15.66% since 01/23/24 | -7.91% since 01/23/24 | -23.24% since 01/23/24 |
| Low | 0.5686 on 01/30/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 1.5800 on 02/02/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -45.97% since 10/23/23 | +0.18% since 10/23/23 | -13.58% since 10/23/23 | +10.13% since 10/23/23 | -23.76% since 10/23/23 |
| Low | 0.1986 on 11/13/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 1.5800 on 02/02/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 83,241 | 145,845,984 | 83,357,904 | 103,362,928 | 28,216,022 |
| Shares Outstanding, K | 119,359 | 536,376 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 8,570,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -276,130,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 4,250,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -60,450,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 0.69 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.56 on 03/28/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 9.93 | 29.34 | 13.20 |